Literature DB >> 623753

Fractionation of aurintricarboxylic acid and effects of its components on nuclear swelling and nucleic acid synthesis.

K Tsutsui, S Seki, K Tsutsui, T Oda.   

Abstract

Crude aurintricarboxylic acid synthesized by the conventional method was fractionated into 8 components (A1-A8) by silica gel thin layer chromatography. Some of the components were isolated and their effects were tested on nuclear swelling and on in vitro RNA synthesis and DNA synthesis using isolated polymerases. Only two components with low RF (A7 and A8) induced strong nuclear swelling. The other components were almost inactive. Formaurin-dicarboxylic acid, a contaminating polyanion of crude aurintricarboxylic acid, was synthesized separately. It was as effective as the two active components in nuclear swelling and inhibited RNA and DNA polymerases on naked DNA template. However, it stimulated RNA synthesis on chromatin template probably by dissociating histones from DNA. Unfractionated aurintricarboxylic acid showed the same effects at higher concentrations. A preliminary analysis indicated one of the inactive components (A4) is genuine aurintricarboxylic acid. The results suggest that the observed activity of crude aurintricarboxylic acid is due to some contaminating substances, one of which is formaurindicarboxylic acid.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 623753     DOI: 10.1016/0005-2787(78)90029-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Characterization of Aurintricarboxylic Acid (ATA) Interactions with Plasma Transporter Protein and SARS-CoV-2 Viral Targets: Correlation of Functional Activity and Binding Energetics.

Authors:  Conceição A Minetti; David P Remeta; Keiji Hashimoto; Radha Bonala; Rajesh Chennamshetti; Xingyu Yin; Miguel Garcia-Diaz; Arthur P Grollman; Francis Johnson; Viktoriya S Sidorenko
Journal:  Life (Basel)       Date:  2022-06-10

2.  In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum.

Authors:  Pavel Klein; Oscar Cirioni; Andrea Giacometti; Giorgio Scalise
Journal:  J Antimicrob Chemother       Date:  2008-07-23       Impact factor: 5.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.